Moderna Therapeutics (United States)
In research, Moderna Therapeutics (United States) stands highest in Life Sciences (#1,041 of 7,800 worldwide), Medicine (#2,843 of 10,443 worldwide) and Health Sciences (#3,982 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Infectious Diseases and Epidemiology — Infectious Diseases is 25.0× its share of world research.
- World rank, 2022–2025
- #2,411 of 28,054 · #4,994 all time
- Rank in United States
- #368 of 4,192
- Research works
- 385 ▲ 594% vs 2013–17
- Citations
- 16k 41.1 per fractional work
- Top-10% rate
- 33.6% record average 16.5%
- Open access
- 78% world 28%
What is Moderna Therapeutics (United States) known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #1,041 of 7,800 | 41.3% | 79 | #2185 | |
| MedicineField | #2,843 of 10,443 | 35.0% | 120 | #6047 | |
| Health SciencesDomain | #3,982 of 11,982 | 34.5% | 125 | #8114 |
Each strip is that field’s whole ranked pool, with the notch where Moderna Therapeutics (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#2,185 #1,041
- Medicine#6,047 #2,843
- Health Sciences#8,114 #3,982
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Moderna Therapeutics (United States) specialise in?
Where its research is concentrated relative to its size: Infectious Diseases takes 25.0× the share of its output that it takes of world research.
- Infectious DiseasesSubfield · 41.5 works25×
- EpidemiologySubfield · 35.9 works10×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.5×. Every wedge is a field page.
- Immunology and Microbiology 7.5×
- Biochemistry, Genetics and Molecular Biology 3.9×
- Medicine 2.6×
- Mathematics 2.2×
- Decision Sciences 1.2×
- Economics, Econometrics and Finance 1.0×
- Pharmacology, Toxicology and Pharmaceutics 0.9×
- Veterinary 0.7×
- Agricultural and Biological Sciences 0.7×
- Health Professions 0.6×
- Energy 0.5×
- Neuroscience 0.5×
- Social Sciences 0.3×
- Nursing 0.3×
- Chemistry 0.3×
- Computer Science 0.2×
- Environmental Science 0.2×
- Materials Science 0.2×
- Dentistry 0.2×
- Psychology 0.2×
- Arts and Humanities 0.1×
- Chemical Engineering 0.1×
- Engineering 0.1×
- Physics and Astronomy 0.1×
Who are the top researchers at Moderna Therapeutics (United States)?
Ranked on the composite score, Jacqueline M. Miller, Weiping Deng and Andrea Carfı́ lead among researchers whose main affiliation is Moderna Therapeutics (United States).
- 1 Jacqueline M. Miller United States · #141,344 worldwide 235 citations · 29 works
- 2 Weiping Deng United States · #422,523 worldwide 137 citations · 16 works
- 3 Andrea Carfı́ United States · #544,414 worldwide 80 citations · 16 works
- 4 Philip O. Buck United States · #604,355 worldwide 50 citations · 23 works
- 5 Ekkehard Beck United States · #1,483,385 worldwide 16 citations · 27 works
Which keywords describe research at Moderna Therapeutics (United States)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Vaccine, Pandemic, SARS-CoV-2, Coronavirus, ACE2 Receptor, Immunity and Viral Transmission.
- Porcine Reproductive and Respiratory Syndrome Virus
- Genomic Sequencing
- Congenital Infection
- Antibodies
- Immune Evasion
- Metagenomics
- Vaccine Hesitancy
- COVID-19 Vaccine
- RNA Interference
- Gene Silencing
- Respiratory Syncytial Virus
- Disease Burden
- Gene Therapy
- Vaccine Development
- antibody
- Immune Response
- Viral Transmission
- ACE2 Receptor
- SARS-CoV-2
- Vaccine
- Epidemiology
- Pandemic
- Coronavirus
- Immunity
- Pathogenesis
- Mutation
- spike protein
- Infection
- Viral Infections
- Human Metapneumovirus
- Transplant Recipients
- Antiviral Therapy
- siRNA Delivery
- Health Behavior
- Antigen Presentation
- Genomics
- Thrombosis
- Virus
- Cytomegalovirus
- Circovirus
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Epidemiology59▲ 6.2×43 topics
- Vaccine44▲ 44×10 topics
- Pandemic38▲ 14×6 topics
- SARS-CoV-231▲ 39×6 topics
- Coronavirus29▲ 57×2 topics
- ACE2 Receptor28▲ 48×2 topics
- Immunity28▲ 28×5 topics
- Viral Transmission25▲ 69×4 topics
- Pathogenesis24▲ 20×14 topics
- Immune Response23▲ 16×12 topics
- Mutation22▲ 48×2 topics
- antibody22▲ 84×1 topic
- spike protein22▲ 84×1 topic
- Vaccine Development22▲ 35×6 topics
- Infection15▲ 26×6 topics
- Gene Therapy15▲ 31×4 topics
- Viral Infections14▲ 103×2 topics
- Disease Burden14▲ 78×2 topics
- Human Metapneumovirus14▲ 123×1 topic
- Respiratory Syncytial Virus14▲ 123×1 topic
- Transplant Recipients10▲ 69×2 topics
- Gene Silencing9▲ 39×2 topics
- Antiviral Therapy9▲ 38×3 topics
- RNA Interference9▲ 44×1 topic
- siRNA Delivery9▲ 63×1 topic
- COVID-19 Vaccine9▲ 48×2 topics
- Health Behavior8▲ 34×1 topic
- Vaccine Hesitancy8▲ 52×1 topic
- Antigen Presentation8▲ 38×2 topics
- Metagenomics8▲ 35×2 topics
- Genomics8▲ 11×3 topics
- Immune Evasion8▲ 67×2 topics
- Thrombosis8▲ 11×3 topics
- Antibodies7▲ 54×2 topics
- Virus7▲ 31×2 topics
- Congenital Infection7▲ 98×1 topic
- Cytomegalovirus7▲ 98×1 topic
- Genomic Sequencing7▲ 25×2 topics
- Circovirus7▲ 92×1 topic
- Porcine Reproductive and Respiratory Syndrome Virus7▲ 92×1 topic
Which research topics does Moderna Therapeutics (United States) publish most on?
By volume in 2022–2025: SARS-CoV-2 and COVID-19 Research, Respiratory viral infections research, RNA Interference and Gene Delivery and Vaccine Coverage and Hesitancy.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 SARS-CoV-2 and COVID-19 Research Infectious Diseases 22 works
- 2 Respiratory viral infections research Epidemiology 14 works
- 3 RNA Interference and Gene Delivery Molecular Biology 9 works
- 4 Vaccine Coverage and Hesitancy Health 8 works
- 5 Cytomegalovirus and herpesvirus research Epidemiology 7 works
- 6 Animal Virus Infections Studies Animal Science and Zoology 7 works
- 7 Viral gastroenteritis research and epidemiology Infectious Diseases 7 works
- 8 Influenza Virus Research Studies Epidemiology 6 works
- 9 COVID-19 Clinical Research Studies Infectious Diseases 6 works
- 10 Virus-based gene therapy research Genetics 5 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Moderna Therapeutics (United States)'s research output changed?
Output in 2018–2022 was 594% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Cambridge
- Harvard University
- Massachusetts Institute of Technology
- Center for Astrophysics Harvard & Smithsonian
- National Bureau of Economic Research
- IIT@MIT
- World Wide Web Consortium
- Broad Institute
- Smithsonian Astrophysical Observatory
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.